Cancer, Cardio, Metabolic Gene Panel Screening - 163 genes

Healthy individuals without a family history of cancer or significant healthy conditions can screen for 163 genes that include:

• cancers (64 genes)
• cardiovascular diseases
• metabolic diseases
• other medically actionable conditions

Report coverage: Pathogenic and likely pathogenic variants in the gene panel.

Benefits: This genetic screening is intended to assess healthy asymptomatic individuals for hereditary conditions, where early detection may enable effective medical interventions and preventive measures.

Limitations: Benign, likely benign, and genetic variants of uncertain significance are not reported. 

Lifelong updates on recategorised variants: If additional evidence becomes available to indicate that a previously unreported genetic change is clinically significant, the laboratory will issue an updated report. 

Sample requested : Saliva, blood in EDTA tube

Reporting time : 28 working days

Laboratory: USA